GB0310361D0 - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
GB0310361D0
GB0310361D0 GBGB0310361.1A GB0310361A GB0310361D0 GB 0310361 D0 GB0310361 D0 GB 0310361D0 GB 0310361 A GB0310361 A GB 0310361A GB 0310361 D0 GB0310361 D0 GB 0310361D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310361.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to GBGB0310361.1A priority Critical patent/GB0310361D0/en
Publication of GB0310361D0 publication Critical patent/GB0310361D0/en
Priority to EP04728848A priority patent/EP1620388A1/en
Priority to PCT/GB2004/001709 priority patent/WO2004099119A1/en
Priority to KR1020057021019A priority patent/KR20060034636A/en
Priority to ARP040101493A priority patent/AR046070A1/en
Priority to CL200400948A priority patent/CL2004000948A1/en
Priority to PA20048602001A priority patent/PA8602001A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0310361.1A 2003-05-06 2003-05-06 Pharmaceutical compound Ceased GB0310361D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0310361.1A GB0310361D0 (en) 2003-05-06 2003-05-06 Pharmaceutical compound
EP04728848A EP1620388A1 (en) 2003-05-06 2004-04-22 Sibutramine free base in crystalline form and its pharmaceutical use
PCT/GB2004/001709 WO2004099119A1 (en) 2003-05-06 2004-04-22 Sibutramine free base in crystalline form and its pharmaceutical use
KR1020057021019A KR20060034636A (en) 2003-05-06 2004-04-22 Sibutramine free base in crystalline form and its pharmaceutical use
ARP040101493A AR046070A1 (en) 2003-05-06 2004-04-30 SIBUTRAMINE AS A FREE BASE IN CRYSTAL FORM AND SALTS, COMPOSITIONS THAT CONTAIN THEM AND USES OF THE SAME
CL200400948A CL2004000948A1 (en) 2003-05-06 2004-05-04 SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY
PA20048602001A PA8602001A1 (en) 2003-05-06 2004-05-06 PHARMACEUTICAL COMPOUND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310361.1A GB0310361D0 (en) 2003-05-06 2003-05-06 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
GB0310361D0 true GB0310361D0 (en) 2003-06-11

Family

ID=9957512

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310361.1A Ceased GB0310361D0 (en) 2003-05-06 2003-05-06 Pharmaceutical compound

Country Status (7)

Country Link
EP (1) EP1620388A1 (en)
KR (1) KR20060034636A (en)
AR (1) AR046070A1 (en)
CL (1) CL2004000948A1 (en)
GB (1) GB0310361D0 (en)
PA (1) PA8602001A1 (en)
WO (1) WO2004099119A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073292A1 (en) * 2005-01-06 2006-07-13 Cj Corporation Inorganic acid salts of sibutramine
KR100814384B1 (en) * 2006-02-10 2008-03-18 대화제약 주식회사 Pharmaceutical composition containing sibutramine salt, and manufacturing method thereof
KR100806673B1 (en) * 2006-06-23 2008-03-03 주식회사 대희화학 Process for Preparing Crystalline Sibutramine Free Base

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound

Also Published As

Publication number Publication date
CL2004000948A1 (en) 2005-04-22
PA8602001A1 (en) 2004-11-26
KR20060034636A (en) 2006-04-24
AR046070A1 (en) 2005-11-23
WO2004099119A1 (en) 2004-11-18
EP1620388A1 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0218625D0 (en) Pharmaceutical compounds
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
GB0300427D0 (en) Pharmaceutical composition
GB0308511D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0317315D0 (en) Pharmaceutical compounds
GB0328490D0 (en) Medicinal compounds
GB0300885D0 (en) Pharmaceutical composition
GB0313766D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
GB2401043B (en) Drug
GB0316889D0 (en) Pharmaceutical agents
GB0306933D0 (en) Pharmaceutical composition
GB0204392D0 (en) Pharmaceutical compound
GB0310361D0 (en) Pharmaceutical compound
GB0307869D0 (en) Pharmaceutical composition
GB0329617D0 (en) Pharmaceutical compounds
GB0307864D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)